Raia Drogasil S.A. (OTCMKTS:RADLY) Short Interest Update

Raia Drogasil S.A. (OTCMKTS:RADLY) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totaling 25,098 shares, a decline of 93.8% from the July 15th total of 402,126 shares. Based on an average daily trading volume, of 15,813 shares, the days-to-cover ratio is currently 1.6 days. Approximately 0.0% of the company’s stock are sold short.

Raia Drogasil Stock Down 6.8%

Shares of Raia Drogasil stock traded down $0.26 on Tuesday, hitting $3.56. The company had a trading volume of 5,629 shares, compared to its average volume of 160,096. The stock has a 50-day moving average of $3.57 and a 200-day moving average of $4.20. Raia Drogasil has a twelve month low of $3.01 and a twelve month high of $5.34.

Raia Drogasil (OTCMKTS:RADLY) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, meeting the consensus estimate of $0.05. The company had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.32 billion. On average, equities research analysts anticipate that Raia Drogasil will post 0.17 EPS for the current fiscal year.

About Raia Drogasil

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.